The Chinese University of Hong Kong
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1963-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cuhk.edu.hk
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
Phase 4
Completed
- Conditions
- Lupus NephritisLupus Erythematosus, Systemic
- First Posted Date
- 2005-08-01
- Last Posted Date
- 2015-08-03
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 20
- Registration Number
- NCT00125307
- Locations
- 🇭🇰
Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong
Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)
Phase 3
Completed
- Conditions
- Subarachnoid Hemorrhage
- Interventions
- Drug: Intravenous magnesium sulfate infusion
- First Posted Date
- 2005-07-27
- Last Posted Date
- 2009-12-23
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 327
- Registration Number
- NCT00124150
- Locations
- 🇨🇳
Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China
Treatment of Tennis Elbow With Botulinum Toxin
Phase 3
Completed
- Conditions
- Epicondylitis, Lateral Humeral
- First Posted Date
- 2005-07-14
- Last Posted Date
- 2006-05-09
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 60
- Registration Number
- NCT00119704
- Locations
- 🇭🇰
Prince of Wales Hospital, Shatin, New Territories, Hong Kong
🇭🇰North District Hospital, Sheung Shui, New Territories, Hong Kong